OFF LABEL MARKETING

BUSINESS
Is the FDA Ready for Kim Kardashian and Mutant Head Lice?
By Molly Knobler, Contributor
Whistleblower lawyer with a focused practice in health care an...
Misleading pharmaceutical marketing can be far more insidious than Kim Kardashian's recent social media flub with Diclegis, and it is with these more serious transgressions that the FDA must keep a careful eye.
HEALTHY LIVING
Drug Company GlaxoSmithKline Puts American Values to Shame
By Dr. Peter Breggin, Contributor
reform psychiatrist
The capacity of government and its citizens to sue entities such as pharmaceutical company GlaxoSmithKline for fraudulent practices is a necessary part of the checks and balances needed to restrain personal and corporate greed.
BUSINESS
Pfizer Rapamune Lawsuit: Pharma Giant's Subsidiary Accused Of Targeting 'High-Risk' Black Patients For Unapproved Use Of Drug
By Marcus Baram